Lextrading

50sma retest at $55. Looking like a H&S formation.

Short
NASDAQ:CRSP   CRISPR Therapeutics AG
Daily doesn't look good. Grinding down.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.